Shree Saibaba Exim Private Limited, a promoter group entity of Evexia Lifecare Limited , acquired 2,03,95,000 equity shares in the company on September 2, 2026. The transaction was executed through the open market, significantly increasing the entity’s holding.

The acquisition was disclosed under Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Additionally, the purchase triggered a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

Prior to this transaction, Shree Saibaba Exim held 64,624 equity shares, representing 0.003% of the total share capital. Following the purchase, its total holding stands at 2,04,59,624 shares, or 1.089% of the voting capital.

The total equity share capital of Evexia Lifecare remains unchanged at 187,73,28,995 shares with a face value of Re. 1/- each. There were no encumbrances, pledges, or convertible securities involved in this transaction.

What the Numbers Show

The jump in shareholding from 0.003% to 1.089% indicates a strategic consolidation of promoter group interest rather than a passive accumulation. With no derivatives trading reported alongside this open market purchase, the move reflects a direct equity commitment by the promoter group entity.

Evexia Lifecare Limited announced the approval of its unaudited financial results for the quarter ended June 30, 2026, during a board meeting held on August 7, 2026. The disclosure, made pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that the company’s financial performance for Q1FY27 has been reviewed by its statutory auditors. Investors seeking detailed metrics can access the full financial statements and the limited review report via the company’s website or through the Quick Response (QR) code provided in the official filing.

The approval process followed standard corporate governance protocols, with the Audit Committee recommending the results to the Board of Directors prior to ratification. Jayesh Raichandbhai Thakkar, Chairman and Managing Director of Evexia Lifecare Limited, signed off on the announcement from Vadodara. The company simultaneously published advertisements in Financial Express (English) and Financial Express (Gujarati) on August 8, 2026, to ensure broad dissemination among stakeholders.

Regulatory Compliance

The filing adheres to the SEBI Listing Regulations, specifically Regulations 30 and 47, which mandate timely disclosure of material events and financial results. The limited review report submitted by the statutory auditors provides assurance over the unaudited financial information presented for the quarter. This procedural step is critical for maintaining transparency and regulatory compliance for listed entities in India.

Key Details

What the Numbers Show

While the specific revenue and profit figures are contained within the linked financial statements rather than the press release text itself, the issuance of a limited review report indicates that the statutory auditors have completed their preliminary examination of the quarter’s accounts. For investors monitoring Evexia Lifecare Limited, the availability of these documents on the corporate website allows for immediate analysis of operational performance and balance sheet health for Q1FY27.